A review of stimuli-responsive nanocarriers for drug and gene delivery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Couvreur, 2006, Nanotechnology: intelligent design to treat complex disease, Pharm. Res., 23, 1417, 10.1007/s11095-006-0284-8
Torchilin, 2007, Targeted pharmaceutical nanocarriers for cancer therapy and imaging, AAPS J., 9, 128, 10.1208/aapsj0902015
Moghimi, 2005, Nanomedicine: current status and future prospects, FASEB J., 19, 311, 10.1096/fj.04-2747rev
Torchilin, 2006, Multifunctional nanocarriers, Adv. Drug Deliv. Rev., 58, 1532, 10.1016/j.addr.2006.09.009
Shenoy, 2005, Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies, Pharm. Res., 22, 2107, 10.1007/s11095-005-8343-0
Shenoy, 2005, Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. in vitro evaluations, Mol. Pharmacol., 2, 357, 10.1021/mp0500420
Shenoy, 2005, Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer, Int. J. Pharm., 293, 261, 10.1016/j.ijpharm.2004.12.010
Kommareddy, 2005, Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione, Bioconjug. Chem., 16, 1423, 10.1021/bc050146t
Vaupel, 1989, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res., 49, 6449
Meyer, 2001, Drug targeting using thermally responsive polymers and local hyperthermia, J. Control. Release, 74, 213, 10.1016/S0168-3659(01)00319-4
Saito, 2003, Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities, Adv. Drug Deliv. Rev., 55, 199, 10.1016/S0169-409X(02)00179-5
Arrueboa, 2007, Magnetic nanoparticles for drug delivery, Nano Today, 2, 22, 10.1016/S1748-0132(07)70084-1
Gould, 2006, Nanomagnetism shows in vivo potential, Nano Today, 1, 34, 10.1016/S1748-0132(06)70115-3
Ito, 2005, Medical application of functionalized magnetic nanoparticles, J. Biosci. Bioeng., 100, 1, 10.1263/jbb.100.1
Rapoport, 2006
Rapoport, 2002, Ultrasound-activated drug delivery, Drug Deliv. Syst. Sci., 2, 37
Gao, 2005, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound, J. Control. Release, 102, 203, 10.1016/j.jconrel.2004.09.021
Rapoport, 2007, Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery, Prog. Polym. Sci., 32, 962, 10.1016/j.progpolymsci.2007.05.009
Maeda, 1989, Tumouritropic and lymphotropic principles of macromolecular drugs, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
Ohtsuka, 1987, Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes, Cancer, 59, 1560, 10.1002/1097-0142(19870501)59:9<1560::AID-CNCR2820590905>3.0.CO;2-J
van Vlerken, 2007, Modulation of Intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer, Cancer Res., 67, 4843, 10.1158/0008-5472.CAN-06-1648
Allen, 2004, Drug delivery systems: entering the mainstream, Science, 303, 1818, 10.1126/science.1095833
Davis, 1997, Biomedical applications of nanotechnology — implications for drug targeting and gene therapy, Trends Biotechnol., 15, 217, 10.1016/S0167-7799(97)01036-6
Devalapally, 2007, Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer, Int. J. Cancer, 121, 1830, 10.1002/ijc.22886
Kommareddy, 2005, Long-circulating polymeric nanovectors for tumor-selective gene delivery, Technol. Cancer Res. Treat., 4, 615, 10.1177/153303460500400605
Kaul, 2002, Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery, Pharm. Res., 19, 1061, 10.1023/A:1016486910719
Kaul, 2005, Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies, Pharm. Res., 22, 951, 10.1007/s11095-005-4590-3
Kaul, 2005, Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles, J. Pharm. Sci., 94, 184, 10.1002/jps.20216
Kommareddy, 2007, Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery, Nanomed., 3, 32, 10.1016/j.nano.2006.11.005
Wagner, 2007, Programmed drug delivery: nanosystems for tumor targeting, Expert. Opin. Biol. Ther., 7, 587, 10.1517/14712598.7.5.587
Sergeeva, 2006, Display technologies: application for the discovery of drug and gene delivery agents, Adv. Drug Deliv. Rev., 58, 1622, 10.1016/j.addr.2006.09.018
Schluesener, 2004, Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display, J. Neurol. Sci., 224, 77, 10.1016/j.jns.2004.06.010
Bongartz, 2006, Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials, JAMA, 295, 2275, 10.1001/jama.295.19.2275
Farokhzad, 2006, Nanoparticle–aptamer bioconjugates for cancer targeting, Expert. Opin. Drug. Deliv., 3, 311, 10.1517/17425247.3.3.311
Kirpotin, 2006, Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models, Cancer Res., 66, 6732, 10.1158/0008-5472.CAN-05-4199
Elbayoumi, 2007, Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents, J. Liposome Res., 17, 1, 10.1080/08982100601186474
Gupta, 2007, Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice, Cancer Immunol. Immunother., 1215, 10.1007/s00262-006-0273-0
Sahoo, 2005, Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention, Mol. Pharm., 2, 373, 10.1021/mp050032z
Blessing, 2001, Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery, Bioconjug. Chem., 12, 529, 10.1021/bc0001488
Leiden, 1995, Gene therapy — promise, pitfalls, and prognosis, N. Engl. J. Med., 333, 871, 10.1056/NEJM199509283331310
Oishi, 2007, Synthesis, characterization, and biomedical applications of core–shell-type stimuli-responsive nanogels — nanogel composed of poly[2-(N,N-diethylamino)ethyl methacrylate] core and PEG tethered chains, React. Funct. Polym., 67, 1311, 10.1016/j.reactfunctpolym.2007.07.009
Torchilin, 2006, Recent approaches to intracellular delivery of drugs and DNA and organelle targeting, Annu. Rev. Biomed. Eng., 8, 343, 10.1146/annurev.bioeng.8.061505.095735
Kichler, 2001, Polyethylenimine-mediated gene delivery: a mechanistic study, J. Gene Med., 3, 135, 10.1002/jgm.173
Ogris, 2002, Targeting tumors with non-viral gene delivery systems, Drug Discov. Today, 7, 479, 10.1016/S1359-6446(02)02243-2
Gupta, 2006, Transactivating transcriptional activator-mediated drug delivery, Expert. Opin. Drug Deliv., 3, 177, 10.1517/17425247.3.2.177
Snyder, 2001, Protein/peptide transduction domains: potential to deliver large DNA molecules into cells, Curr. Opin. Mol. Ther., 3, 147
Lundberg, 2003, Cell surface adherence and endocytosis of protein transduction domains, Mol. Ther., 8, 143, 10.1016/S1525-0016(03)00135-7
Weissig, 2001, Drug and DNA delivery to mitochondria, Adv. Drug Deliv. Rev., 49, 1, 10.1016/S0169-409X(01)00122-3
Gerweck, 1996, Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer, Cancer Res., 56, 1194
Hunt, 1986, Engineering targeted In vivo drug delivery I. The physiological & physicochemical principles governing opportunities & limitations, Pharm. Res., 3, 333, 10.1023/A:1016332023234
Bolot, 1998, Analysis of glycosphingolipids of human head and neck carcinomas with comparison to normal tissue, Biochem. Mol. Biol. Int., 46, 125
Gal, 1981, Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism, Int. J. Cancer, 28, 315, 10.1002/ijc.2910280310
Wike-Hooley, 1984, The relevance of tumour pH to the treatment of malignant disease, Radiother. Oncol., 2, 343, 10.1016/S0167-8140(84)80077-8
Dewhirst, 2005, Re-setting the biologic rationale for thermal therapy Int, J. Hyperth., 21, 779, 10.1080/02656730500271668
Jin, 2007, Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer, Adv. Exp. Med. Biol., 599, 45, 10.1007/978-0-387-71764-7_7
Gupta, 2007, Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications, Nanomed., 2, 23, 10.2217/17435889.2.1.23
Ahmed, 2005, Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time, J. Vasc. Interv. Radiol., 16, 1365, 10.1097/01.RVI.0000175324.63304.25
Ponce, 2006, Hyperthermia mediated liposomal drug delivery, Int. J. Hyperthon., 22, 205, 10.1080/02656730600582956
Mahato, 2002
Oupicky, 2001, Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo, Gene Ther., 8, 713, 10.1038/sj.gt.3301446
Schafer, 2001, Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple, Free Radic. Biol. Med., 30, 1191, 10.1016/S0891-5849(01)00480-4
Collins, 1991, Reduction of disulfide bonds within lysosomes is a key step in antigen processing, J. Immunol., 147, 4054, 10.4049/jimmunol.147.12.4054
Neu, 2007, Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: In vitro characterization and in vivo studies in mice, J. Control. Release, 118, 370, 10.1016/j.jconrel.2007.01.007
Shim, 2007, pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel, Int. J. Pharm., 331, 11, 10.1016/j.ijpharm.2006.09.027
Kim, 1994, pH/temperature-sensitive polymers for macromolecular drug loading and release, J. Control. Release, 28, 143
Benns, 2000, pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(l-histidine)-graft-poly(l-lysine) comb shaped polymer, Bioconjug. Chem., 11, 637, 10.1021/bc0000177
Dufresne, 2004, Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery, Int. J. Pharm, 277, 81, 10.1016/j.ijpharm.2003.07.014
Bae, 2005, Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy, Bioconjug. Chem., 16, 122, 10.1021/bc0498166
Bae, 2005, Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery, Mol. Bio. Syst., 1, 242, 10.1039/b500266d
Liua, 2007, Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs, Biomaterials, 28, 1423, 10.1016/j.biomaterials.2006.11.013
Lee, 2003, Polymeric micelle for tumor pH and folate-mediated targeting, J. Control. Release, 91, 103, 10.1016/S0168-3659(03)00239-6
Ishida, 2001, Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells, Biochim. Biophys. Acta, 1515, 144, 10.1016/S0005-2736(01)00409-6
Shigeta, 2007, Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells, J. Control. Release, 118, 262, 10.1016/j.jconrel.2006.12.019
Yamada, 2005, Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy, Int. J. Pharm., 303, 1, 10.1016/j.ijpharm.2005.06.009
Fattal, 2004, “Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes, Adv. Drug Deliv. Rev., 56, 931, 10.1016/j.addr.2003.10.037
Hui, 2005, Thermo- and pH-sensitive dendrimer derivatives with a shell of poly(N,N-dimethylaminoethyl methacrylate) and study of their controlled drug release behavior, Polymer, 46, 9514, 10.1016/j.polymer.2005.07.034
Lai, 2007, Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy, J. Control. Release, 122, 39, 10.1016/j.jconrel.2007.06.012
Devalapally, 2007, Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model, Cancer Chemother. Pharmacol., 59, 477, 10.1007/s00280-006-0287-5
Na, 2003, Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro, J. Control. Release, 87, 3, 10.1016/S0168-3659(02)00345-0
Murthy, 2003, Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides, J. Control. Release, 89, 365, 10.1016/S0168-3659(03)00099-3
Bulmus, 2003, A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs, J. Control. Release, 93, 105, 10.1016/j.jconrel.2003.06.001
Stayton, 2005, ‘Smart’ delivery systems for biomolecular therapeutics, Orthod. Craniofac. Res., 8, 219, 10.1111/j.1601-6343.2005.00336.x
Kamada, 2004, Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy, Clin. Cancer Res., 10, 2545, 10.1158/1078-0432.CCR-03-0544
Ulbrich, 2000, Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation, J. Control. Release, 64, 63, 10.1016/S0168-3659(99)00141-8
Ulbrich, 2004, Antibody-targeted polymer–doxorubicin conjugates with pH-controlled activation, J. Drug Target, 12, 477, 10.1080/10611860400011869
Kratz, 1998, Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy, J. Pharm. Sci., 87, 338, 10.1021/js970246a
Beyer, 1998, Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil, J. Med. Chem., 41, 2701, 10.1021/jm9704661
Drevs, 1999, In vivo and in vitro efficacy of an acid-sensitive albumin conjugate of adriamycin compared to the parent compound in murine renal-cell carcinoma, Drug Deliv., 6, 89, 10.1080/107175499267002
Tomlinson, 2003, Polyacetal–doxorubicin conjugates designed for pH-dependent degradation, Bioconjug. Chem., 14, 1096, 10.1021/bc030028a
Torchillin, 2005, Recent advances with liposomes as pharmaceutical carriers, Nat. Rev., Drug Discov., 4, 145, 10.1038/nrd1632
Papanicolaou, 2004, Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer, J. Drug Target, 12, 541, 10.1080/10611860400011950
Simoes, 2004, On the formulation of pH-sensitive liposomes with long circulation times, Adv. Drug Deliv. Rev., 56, 947, 10.1016/j.addr.2003.10.038
Roux, 2004, Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes, J. Control. Release, 94, 447, 10.1016/j.jconrel.2003.10.024
Kakudo, 2004, Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system, Biochemistry, 43, 5618, 10.1021/bi035802w
Wang, 1989, Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes, Biochemistry, 28, 9508, 10.1021/bi00450a039
Litzinger, 1992, Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications, Biochim. Biophys. Acta, 1113, 201, 10.1016/0304-4157(92)90039-D
Connor, 1986, pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs, Cancer Res., 46, 3431
Couvreur, 1997, pH-sensitive liposomes: an intelligent system for the delivery of antisense oligonucleotides, J. Liposome Res., 7, 1, 10.3109/08982109709035478
Couffin-Hoarau, 2004, Report on the use of poly(organophosphazenes) for the design of stimuli-responsive vesicles, Biomacromolecules, 5, 2082, 10.1021/bm0400527
Leroux, 2001, N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles, J. Control. Release, 72, 71, 10.1016/S0168-3659(01)00263-2
Ellens, 1984, pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact, Biochemistry, 23, 1532, 10.1021/bi00302a029
Lee, 1998, The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery, Biosci. Rep., 18, 69, 10.1023/A:1020132226113
Kataoka, 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv. Drug Deliv. Rev., 47, 113, 10.1016/S0169-409X(00)00124-1
Kwon, 1996, Polymeric micelles as new drug carriers, Adv. Drug Deliv. Rev., 21, 107, 10.1016/S0169-409X(96)00401-2
Gillies, 2004, Development of acid sensitive copolymer micelles for drug delivery, Pure Appl. Chem., 76, 1295, 10.1351/pac200476071295
Shim, 2006, Novel pH sensitive block copolymer micelles for solvent free drug loading, Macromol. Biosci., 6, 179, 10.1002/mabi.200500182
Lee, 2003, Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization, J. Control. Release, 90, 363, 10.1016/S0168-3659(03)00205-0
Low, 1995, Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro, Biochem. Biophys. Acta, 1233, 134, 10.1016/0005-2736(94)00235-H
Reddy, 1998, Folate-mediated targeting of therapeutic and imaging agents to cancers, Crit. Rev. Ther. Drug Carrier Syst., 15, 587, 10.1615/CritRevTherDrugCarrierSyst.v15.i6.20
Ross, 1994, Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications, Cancer, 73, 2432, 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
Lee, 2005, Super pH-sensitive multifunctional polymeric micelle, Nano Lett., 5, 325, 10.1021/nl0479987
Shen, 2000, Control of architecture in block-copolymer vesicles, Angew. Chem., Int. Ed., 10.1002/1521-3757(20000915)112:18<3448::AID-ANGE3448>3.0.CO;2-A
Liu, 2003, Synthesis and aqueous solution behavior of a pH-responsive schizophrenic diblock copolymer, Langmuir, 19, 4432, 10.1021/la020951l
Bütün, 2001, The remarkable “flip-flop” self-assembly of a diblock copolymer in aqueous solution, Macromolecular, 34, 1503, 10.1021/ma0018392
Heskins, 1968, Solution properties of poly(N-isopropylacrylamide, J. Macromol. Sci. Chem., A2, 1441, 10.1080/10601326808051910
Beltran, 1991, Swelling equilibria for weakly ionizable, temperature-sensitive hydrogels, Macromolecular, 24, 549, 10.1021/ma00002a032
Hsiue, 2006, Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(l-lactide) diblock copolymer for application in drug delivery, Int. J. Pharm., 317, 69, 10.1016/j.ijpharm.2006.03.002
Taillefer, 2000, Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs, J. Pharm. Sci., 89, 52, 10.1002/(SICI)1520-6017(200001)89:1<52::AID-JPS6>3.0.CO;2-D
Le Garrec, 2002, Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model, J. Drug Target., 10, 429, 10.1080/1061186021000001887
McLennan, 1985, A nuclear magnetic resonance study of the self-association of adriamycin and daunomycin in aqueous solution, Can. J. Chem., 63, 1233, 10.1139/v85-210
Kataoka, 2000, Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance, J. Control. Release, 64, 143, 10.1016/S0168-3659(99)00133-9
Tomalia, 1985, A new class of polymers: starburst-dendritic macromolecules, Polym. J. (Tokyo), 17, 117, 10.1295/polymj.17.117
Esfand, 2001, Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications, Drug Discov. Today, 6, 427, 10.1016/S1359-6446(01)01757-3
Ihre, 2002, Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization, Bioconju. Chem., 13, 443, 10.1021/bc010102u
Gillies, 2004, Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers, J. Am. Chem. Soc., 126, 11936, 10.1021/ja0463738
Na, 2006, Biodegradable thermo-sensitive nanoparticles from poly(l-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier, Eur. J. Pharm. Sci., 27, 115, 10.1016/j.ejps.2005.08.012
Chung, 1999, Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate), J. Control. Release, 62, 115, 10.1016/S0168-3659(99)00029-2
Kong, 2000, Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release, Cancer Res., 60, 6950
Hayashi, 1996, Temperature-controlled release property of phospholipid vesicles bearing a thermo-sensitive polymer, Biochim. Biophys. Acta, 1280, 127, 10.1016/0005-2736(95)00273-1
Wells, 2003, Localized delivery to CT-26 tumors in mice using thermosensitive liposomes, Int. J. Pharm., 261, 105, 10.1016/S0378-5173(03)00290-4
Kale, 2007, Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified PEGylated liposomes, J. Drug Target., 15, 538, 10.1080/10611860701498203
Cavallaro, 2006, Reversibly stable thiopolyplexes for intracellular delivery of genes, J. Control. Release, 115, 322, 10.1016/j.jconrel.2006.07.027
Balakirev, 2000, Lipoic acid-derived amphiphiles for redox-controlled DNA delivery, Chem. Biol., 7, 813, 10.1016/S1074-5521(00)00030-2
Anderson, 1988, Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol, Life Sci., 42, 1493, 10.1016/0024-3205(88)90005-7
Rijcken, 2007, Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery, J. Control. Release, 120, 131, 10.1016/j.jconrel.2007.03.023
Yoshida, 1995, Comb-type grafted hydrogels with rapid deswelling response to temperature changes, Nature, 374, 240, 10.1038/374240a0
Kim, 2000, Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors, J. Control. Release, 65, 345, 10.1016/S0168-3659(99)00207-2
Bae, 2006, Thermosensitive pluronic micelles stabilized by shell cross-linking with gold nanoparticles, Langmuir, 22, 6380, 10.1021/la0606704
Molineux, 2002, PEGylation: engineering improved pharmaceuticals for enhanced therapy, Cancer Treat. Rev., 28, 13, 10.1016/S0305-7372(02)80004-4
Chung, 2000, Inner core segment design for drug delivery control of thermo-responsive polymeric micelles, J. Control. Release, 65, 93, 10.1016/S0168-3659(99)00242-4
Yokoyama, 2002, Gene delivery using temperature responsive polymeric carriers, Drug Discov. Today, 7, 426, 10.1016/S1359-6446(02)02216-X
Liu, 2003, Thermally responsive polymeric micellar nanoparticles self-assembled from cholesteryl end-capped random poly (N-isopropylacrylamide-co-N,N-dimethylacrylamide): synthesis, temperature-sensitivity, and morphologies, J. Colloid Interface Sci., 266, 295, 10.1016/S0021-9797(03)00691-X
Turk, 2004, In vitro transfection of HeLa cells with temperature sensitive polycationic copolymers, J. Control. Release, 96, 325, 10.1016/j.jconrel.2004.01.013
Türk, 2007, Smart and cationic poly(NIPA)/PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies, J. Tissue Eng. Regen. Med., 1, 377, 10.1002/term.47
Piskin, 2004, Gene delivery: intelligent but just at the beginning, J. Biomater. Sci., 15, 1181, 10.1163/1568562041753016
Piskin, 2005, Stimuli-responsive polymers in gene delivery, Expert Rev. Med. Devices, 2, 501, 10.1586/17434440.2.4.501
Twaites, 2004, Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro, J. Control. Release, 97, 551, 10.1016/j.jconrel.2004.03.032
Twaites, 2005, Thermoresponsive polymers as gene delivery vectors: cell viability, DNA transport and transfection studies, J. Control. Release, 108, 472, 10.1016/j.jconrel.2005.08.009
Yatvin, 1978, Design of liposomes for enhanced local release of drugs by hyperthermia, Science, 202, 1290, 10.1126/science.364652
Kono, 2001, Thermosensitive polymer-modified liposomes, Adv. Drug Deliv. Rev., 53, 307, 10.1016/S0169-409X(01)00204-6
Schild, 1992, Poly(N-isopropylacrylamide): experiment, theory and application, Prog. Polym. Sci., 17, 163, 10.1016/0079-6700(92)90023-R
Kono, 1999, Thermosensitive polymer-modified liposomes that release contents around physiological temperature, Biochim. Biophys. Acta, 1416, 239, 10.1016/S0005-2736(98)00226-0
Kono, 1999, Temperature-dependent interaction of thermo-sensitive polymer-modified liposomes with CV1 cells, FEBS Lett., 456, 306, 10.1016/S0014-5793(99)00975-8
Kono, 2002, Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes, J. Control. Release, 80, 321, 10.1016/S0168-3659(02)00018-4
Han, 2006, Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum, Eur. J. Pharm. Biopharm., 62, 110, 10.1016/j.ejpb.2005.07.006
Chandaroy, 2001, Temperature-controlled content release from liposomes encapsulating Pluronic F127, J. Control. Release, 76, 27, 10.1016/S0168-3659(01)00429-1
Ward, 2001, Systemic circulation of poly (l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy, Blood, 97, 2221, 10.1182/blood.V97.8.2221
Kwoh, 1999, Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver, Biochim. Biophys. Acta, 1444, 171, 10.1016/S0167-4781(98)00274-7
Niculescu, 2000, Technology evaluation: gemtuzumab ozogamicin, Celltech Group, Curr. Opin. Mol. Ther., 2, 691
Carlisle, 2004, Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction, J. Gene Med., 6, 337, 10.1002/jgm.525
Wang, 2006, The development and characterization of a glutathione-sensitive cross-linked polyethylenimine gene vector, Biomaterials, 27, 5292, 10.1016/j.biomaterials.2006.05.049
Schmitz, 2007, Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system, Biomaterials, 28, 524, 10.1016/j.biomaterials.2006.08.017
Kevin, 2005, Reversible covalent chemistry in drug delivery, Cur. Drug Discov. Tech., 2, 123, 10.2174/1570163054866882
Zhaohua, 2005, Thiocholesterol-based lipids for ordered assembly of bioresponsive gene carriers, Mol. Ther., 11, 409, 10.1016/j.ymthe.2004.10.013
Kirpotin, 1996, Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol), FEBS Lett., 388, 115, 10.1016/0014-5793(96)00521-2